DRAXIS Health Inc. News Releases - - February 16, 2005 DRAXIS Diagnostic Radiopharmaceutical Approved in First European Country Approval in Netherlands for MAA diagnostic kit for lung imaging paves way for additional products and countries across Europe MISSISSAUGA, Ontario – February 16, 2005 – DRAXIS Health Inc.
http://www.fda.gov/cder/orange/appendix_a.txt 2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO, SECRETIN...
http://www.fda.gov/cdrh/pdf2/p990065c.pdf Dose Reduction Factors for Patients with Lung Shunting % Lung shunting 1 Reduction Factor < 10 Yo I No reduction Lung Shunt Calculation Procedure: Inject 4 mCi (1 5OMBq) of Tc - 99m MAA into the hepatic artery via a port or catheter Use a large FOV gamma camera, and obtain anterior and posterior images of the chest and abdomen (with 700k to 1 million counts on...
Prescription and OTC Drug Product List 1/1998 IRRIGANT AEROSOL, METERED; INHALATION - DLT - AT GLAXO WELLCOME EQ 40MG BASE/ML; ATROVENT - DLT - 200,000 UNITS/ML N60707 001 - DLT - BOEHRINGER INGELHEIM 0.018MG/INH N19085 001 - ADD - AT MONARCH PHARMS EQ 40MG BASE/ML; - DLT - DEC 29, 1986 - ADD - 200,000 UNITS/ML N60707 001 - ADD - + 0.018MG/INH N19085 001 - ADD - DEC 29, 1986 PERMETHRIN ISOSULFAN BLUE CREAM; TOPICAL ELIMITE...
Prescription and OTC Drug Product List 3/1999 Prescription and Over-the-Counter Drug Product List - 19th Edition Cumulative Supplement Number 3: March 1999 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CAPSULE; ORAL CHLORIDE; SODIUM PHOSPHATE...
Drug Approvals - M NDA 13-422/S-035 4/17/03 - - - Maxipime (Cefepime Hydrochloride) Injection,-Rx Bristol-Myers Squibb NDA 50-679/S-21 3/17/03 3/26/03 3/26/03 Maxipime (Cefepime Hydrochloride) Injection,- Bristol-Myers Squibb NDA 50-679/S-009, S-014 and S-018 8/21/02 8/26/02 - Maxipime (Cefepime Hydrochloride) Injection Bristol-Myers Squibb NDA 50-679/S007 1/27/99 - - 7/18/01 Maxitrol (neomycin and...
chrmscat.p65 page 1
author: cxm9300
LIST OF APPROVED DRUGS FOR WHICH ADDITIONAL PEDIATRIC INFORMATION Oncology Drug Products Technetium Tc -99m Albumin Aggregated Scintigraphic imaging of the lungs as an adjunct to other diagnostic procedures whenever information about pulmonary circulation is neededTechnetium Tc -99m Apcitide Scintigraphic imaging of acute venous thrombosis in the...
may20lst.PDF Iofetamine I- 123 Radioactive diagnostic- nonlacunar stroke Yes Yes Yes Yes Iopromide Aortography and visceral angiography coronary arteriography/ left ventriculography Yes Yes No No Iotrolan For contrast enhancement for lumbar, thoracic, cervical and total columnar myelography of spinal and subarachnoid spaces Yes Yes Yes Yes Ioversol Radiopaque diagnostic (cerebral angiography and...
author: Unknown
may20lst.PDF page 10
author: Unknown
C:\Data\My Documents\CMC Supplements\NDA17881\scm004APltr7-23-02.do\ c page 1
author: Patricia Stewart
PII: S0969-8051(01)00218-9 page 4
doi:10.1016/S0969-8051(03)00028-3 page 7
http://www.neoprobe.com/UCSD/ASOwallace2003.pdf page 8
Prescription and OTC Drug Product List 6/2002 -A- + GD SEARLE LLC EQ 500MG BASE/VIAL N18353 001 JUL CAHN -D- + SCS EQ 500MG BASE/VIAL N18353 001 JUL CAHN MIDAZOLAM HYDROCHLORIDE INJECTABLE; INJECTION MIDAZOLAM HCL -A- AP ABBOTT EQ 1MG BASE/ML N75857 001 JUL 22, 2002 JUL NEWA -A- AP EQ 5MG BASE/ML N75857 002 JUL 22, 2002 JUL NEWA MIDODRINE HYDROCHLORIDE TABLET; ORAL PROAMATINE -A- + SHIRE LABS 5MG N19815 002 SEP 06, 1996 JUL CRLD...
Prescription and OTC Drug Product List 6/2002 -D- + WYETH AYERST 20,000 UNITS/VIAL N17055 003 JUN DISC -A- @ 20,000 UNITS/VIAL N17055 003 JUN DISC CHORIONIC GONADOTROPIN -D- + STERIS 2,000 UNITS/VIAL N17016 011 FEB 16, 1990 JUN DISC -A- @ 2,000 UNITS/VIAL N17016 011 FEB 16, 1990 JUN DISC GRANISETRON HYDROCHLORID E SOLUTION; ORAL KYTRIL -D- + ROCHE EQ 2MG BASE/10ML N21238 001 JUN 27, 2001 JUN DISC -A- @ EQ 2MG BASE/10ML N21238...
Prescription and OTC Drug Product List 11/1997 Prescription and Over-the-Counter Drug Product List - 17th Edition Cumulative Supplement Number 11: Jan '97 - Nov '97 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACARBOSE AMANTADINE HYDROCHLORIDE TABLET; ORAL CAPSULE; ORAL PRECOSE - DLT - SYMADINE - DLT - BAYER 25MG N20482 004 - DLT - AB SOLVAY 100MG N71000 001 - DLT - MAY 29, 1997 - DLT - SEP 04,...
http://www.fda.gov/cdrh/pdf2/p990065c.pdf page 11
Draxis Form 20-F for FYE 1201 as Filed SEDAR.DOC page 23
author: ChrisO
THE MERCK MANUAL, Sec. 4, Ch. 37, Screening And Diagnostic Evaluation Serum proteins: The liver synthesizes most serum proteins: - and -globulins, albumin, and clotting factors (but not -globulin, which is produced by B lymphocytes).albumin, the main determinant of plasma oncotic pressure, transports numerous substances (eg, unconjugated bilirubin).albumin ...
http://www.neoprobe.com/UCSD/ASOwallace2003.pdf page 1
THE MERCK MANUAL, Sec. 4, Ch. 37, Screening And Diagnostic Evaluation Serum proteins: The liver synthesizes most serum proteins: - and -globulins, albumin, and clotting factors (but not -globulin, which is produced by B lymphocytes)albumin, the main determinant of plasma oncotic pressure, transports numerous substances (eg, unconjugated bilirubin)albumin ...
CMS Releases Final Rule for 2004 Biotechnology Information, Advocacy and Business Support | About Us | BIO Events | BIO Members | Join BIO | Member Services | Links | Home CMS Payment System Prescription Coverage & Reimbursement Food & Agriculture Industrial & Environmental Bioethics & Biomedical Research Intellectual Property Regulatory Policies Tax & Fiscal Policies All Issues & Initiatives Press Releases Company...
Microsoft Word - 11.6.03 OPPS 2004 Final Rule Summary.DOC 1 CMS Releases Hospital Outpatient Prospective Payment System Final Rule for 2004 On October 31, 2003, the Centers for Medicare and Medicaid Services (" CMS") released its final rule entitled "Medicare Program; Changes to the Hospital Outpatient Prospective Payment System (" OPPS") and Calendar Year 2004 Payment Rates" [CMS- 1471- FC] (the "Final Rule")
author: dschulz
Microsoft Word - 11.6.03 OPPS 2004 Final Rule Summary.DOC page 2
author: dschulz
